All Sauce from Weekly Sauce:

A new drug combination for advanced liver cancer can extend people’s lives substantially more than the long-standing drug of choice, new study findings confirm. The treatment involves two drugs approved to fight various cancers: bevacizumab (Avastin) and atezolizumab (Tecentriq). Avastin, an intravenous (IV) drug, starves tumors by preventing new blood vessel growth. Tecentriq, also given…  read on >  read on >

Children in day care centers had low coronavirus infection rates early in the pandemic, and are unlikely sources of COVID-19 transmission, a new study from France finds. COVID-19 can infect people of all ages, but children tend to develop mild, if any, symptoms, and very rarely need to be hospitalized. Very young children’s role as…  read on >  read on >

Fill up that mug: Having one or more cups of caffeinated coffee a day may reduce your risk of heart failure, new research suggests. There was one caveat, however: Decaffeinated coffee doesn’t appear to provide the same protection as caffeine-rich blends. “The association between caffeine and heart failure risk reduction was surprising,” admitted study senior…  read on >  read on >

Keep flossing: A new study finds that gum disease may raise the chances of hospitalization or death if COVID-19 strikes. The reason? Gum disease can be a sign of inflammation throughout the body. “It is well-established that systemic inflammation is not only linked with periodontal disease, but to several other respiratory diseases as well,” explained…  read on >  read on >

Severe frailty significantly increases the risk of death in COVID-19 patients, British researchers say. In their new study, the investigators analyzed data from more than 5,700 COVID-19 patients at 55 hospitals in 12 countries. They found that those who were severely frail were three times more likely to die than those who weren’t frail. That…  read on >  read on >